Current market catalysts

Z Squared Announces Closing Of All-Stock Acquisition Of Paradox Data From Paradox Infrastructure, Adding El Dorado, Arkansas Union County Campus With About 8.0 MW Energized Service; No Cash Paid, No Debt Incurred

HC Wainwright & Co. Reiterates Buy on Emergent BioSolutions, Maintains $10 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Emergent BioSolutions (NYSE:EBS) with a Buy and maintains $10 price target.

Tyra Biosciences Says Phase 2 SURF302 Study Of Oral Dabogratinib In Low-Grade IR NMIBC Showed 79% ORR, 64% Best Overall Complete Response Rate At 60 mg QD; Says 100% ORR In Single Marker Lesion Patients, Identifies 60 mg As Phase 3 Adjuvant Dose

Vietnam Posts And Telecommunications Group Selects RADCOM To Provide AI-Native, Cloud-Native Service Assurance For Its Roaming Network

Replacing the incumbent vendor, VNPT gains AI-driven anomaly detection to safeguard roaming service qualityTEL AVIV, Israel, Sept. 9, 2026 /PRNewswire/ -- RADCOM Ltd. (NASDAQ:RDCM) announced today that VNPT (Vietnam

Wipro And CrowdStrike Launch The Chief Information Security Officer Command Center

The CISO Command Center reinforces Wipro’s consulting-led cybersecurity strategy by enablingenterprises to move from tool-driven operations to an enterprise-wide, risk-led operating model.The Center will be

Ceva Announces UWB Collaboration With LG Electronics Combining Ceva-Waves Baseband, Software With LG UWB RF On TSMC 22nm; Says Undisclosed Major U.S. Semiconductor Company Already Adopted Solution

BKV Intends To Offer $400M Aggregate Principal Amount Of Convertible Senior Notes Due 2031 In Private Offering

BKV Corporation ("BKV" or the "Company") (NYSE:BKV) announced today that it intends to offer, subject to market conditions, $400 million aggregate principal amount of convertible senior notes due 2031

First Majestic Silver Reports Drill Results From San Dimas, Including 2,604 g/t Silver And 43.08 g/t Gold Over 0.88m True Width At Sinaloa-Elia And 2,625 g/t Silver, 58.25 g/t Gold Over 1.30m At Luz Vein

Canterra Minerals Intersects 144m of 0.75% CuEq, Including 76m of 1.00% CuEq at Lundberg Deposit, Newfoundland

Canterra Minerals announced significant drill results from its Buchans Project in Newfoundland, including a 144-meter intercept of 0.75% CuEq at the Lundberg Deposit with a higher-grade 76-meter core of 1.00% CuEq. The company is advancing toward a mineral resource estimate for Lundberg in Q4 2026 and continuing Phase 2 drilling across multiple satellite deposits, with 6,000 meters allocated for broader district exploration.

CAPR Legal Notice: BFA Law Notifies Capricor Therapeutics Investors that Lost Money of the Imminent September 28 Securities Fraud Class Action Deadline

Capricor Therapeutics faces a securities fraud class action lawsuit alleging the company made false statements about its lead product Deramiocel and misrepresented clinical data integrity in its FDA Biologics License Application. The lawsuit was triggered by a 64.5% stock drop on July 27, 2026, following FDA briefing documents that raised concerns about post-hoc changes to the statistical analysis plan. Investors have until September 28, 2026 to request lead plaintiff status.

ODDITY Tech Sees FY2026 Sales $655.974M vs $628.063M Est

ODDITY Tech (NASDAQ:ODD) sees FY2026 sales of $655.974 million vs $628.063 million analyst estimate.

AEye Says Lunar Outpost Entered Multi-Million-Dollar Binding Commitment Backed By NASA Funding To Deploy Apollo Lidar On Pegasus Lunar Terrain Vehicle; Says 25 Customers Now Taking Revenue-Generating Shipments, Up 19% Since Q1

8-K filing — DESTINATION XL GROUP, INC. (DXLG)

Filed: 2026-09-09 AccNo: 0001193125-26-385888 Size: 956 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Pyxis Oncology Announces Updated Data From Ongoing Global Phase 1 Monotherapy Study Evaluating Micvotabart Pelidotin In Patients With 2L+ R/M Head And Neck Squamous Cell Carcinoma

MICVO demonstrated rapid and deep responses, with a 36% confirmed objective response rate (cORR) and 94% disease control rate (DCR), with clinical activity observed across HPV status and prior-treatment

Satellos Bioscience Announces WHO Assigned International Nonproprietary Name Forazapadin To SAT-3247; Says BASECAMP Enrollment Expected To Complete This Quarter, Clinical Data In Q4

8-K filing — FLOTEK INDUSTRIES INC/CN/ (FTK)

Filed: 2026-09-09 AccNo: 0000928054-26-000087 Size: 5 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

BMO Capital Initiates Coverage On Birkenstock Holding with Market Perform Rating, Announces Price Target of $35

BMO Capital analyst Kelly Crago initiates coverage on Birkenstock Holding (NYSE:BIRK) with a Market Perform rating and announces Price Target of $35.

OneWater Marine Announces Definitive Agreement For OceanWorld Group To Acquire Majority Interest In Denison Yachting Subsidiary; Terms Not Disclosed, Expects Close By Year-End

Radiopharm Theranostics Shares Data From Phase 1 Imaging Trial of RAD 301 In Healthy Volunteers And Subjects With Pancreatic Ductal Adenocarcinoma

RAD301 is a peptide-based molecule bound to Gallium-68 (Ga-68) that targets αvβ6-integrin, a cellular marker for tumor invasion and metastatic growth, the expression of which correlates with decreased survival in

Gilat Satellite Networks Unit Datapath Receives $32M+ Pentagon Order For Its DKET Systems; Deliveries Expected Over Next 12 Months

DKET Systems operate across Ku, Ka and X-band networks. The award represents a significant expansion of Gilat DataPath's long-standing DKET activity and further strengthens Gilat Defense's position in larger and

Market-Moving News for September 9th

TTAN: -20% | ServiceTitan shares are trading lower after the company reported Q2 financial results and issued Q3 sales guidance with its midpoint below estimates. CASY: -10% | Casey's General Stores Q1 EPS $7.37

8-K filing — SailPoint, Inc. (SAIL)

Filed: 2026-09-09 AccNo: 0001628280-26-061015 Size: 639 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

LifeStance Health Announces 22.25M Share Secondary Offering By Selling Stockholders; Announces Concurrent Buyback Of 2M Shares From Underwriter, Receives No Proceeds

Seaport Therapeutics Reports Phase 1 Results; GlyphAllo At 375 mg Meets Primary Endpoint With No Driving Impairment; 250 mg Dose Also Achieves Key Secondary Endpoint

Trial met its primary endpoint, showing that evening dosing of GlyphAllo at 375 mg did not impair next-morning driving performance compared to placebo on Day 5, following multiple-day dosingKey secondary endpoint also

Needham Reiterates Buy on IonQ, Maintains $65 Price Target

Needham analyst N. Quinn Bolton reiterates IonQ (NYSE:IONQ) with a Buy and maintains $65 price target.

U.S. Bank Announces Live Pilot Cross-Border Payment Between Its North America And Europe Entities Using USBDC Dollar-Backed Stablecoin On Stellar Blockchain

Sunbelt Rentals Holdings Raises FY2027 Sales Guidance from $11.652B-$11.986B to $11.819B-$12.154B vs $11.906B Est

Sunbelt Rentals Holdings (NYSE:SUNB) raises FY2027 sales outlook from $11.652 billion-$11.986 billion to $11.819 billion-$12.154 billion vs $11.906 billion estimate.

Cocrystal Pharma Announces Last Subject Dosed In Phase 1b Norovirus Challenge Study Of CDI-988; Says No Serious Adverse Events To Date, Preliminary Efficacy Results Expected Late 2026 Or Early 2027

Nasdaq Grants Iveda Additional 180-Calendar-Day Period, Through March 1, 2027, To Regain Compliance With Nasdaq's Minimum Bid Price Requirement

Extension provides additional time through March 1, 2027, as Iveda advances commercial execution across its AI and connected-technology portfolioIveda® (NASDAQ:IVDA),a global provider of AI-powered video intelligence,

8-K filing — Tyra Biosciences, Inc. (TYRA)

Filed: 2026-09-09 AccNo: 0001193125-26-385886 Size: 168 KB Item 8.01: Other Events